X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA VENUS REMEDIES PLETHICO PHARMA/
VENUS REMEDIES
 
P/E (TTM) x -1.1 -862.0 - View Chart
P/BV x 0.0 0.3 6.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
VENUS REMEDIES
Mar-16
PLETHICO PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs395218 181.1%   
Low Rs3182 38.1%   
Sales per share (Unadj.) Rs604.4365.6 165.3%  
Earnings per share (Unadj.) Rs32.51.5 2,185.6%  
Cash flow per share (Unadj.) Rs51.337.9 135.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.6382.5 123.8%  
Shares outstanding (eoy) m34.0811.44 297.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.40.4 85.9%   
Avg P/E ratio x6.6101.0 6.5%  
P/CF ratio (eoy) x4.24.0 104.9%  
Price / Book Value ratio x0.50.4 114.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2621,717 423.1%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,596324 492.0%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m20,5984,183 492.5%  
Other income Rs m38620 1,922.1%   
Total revenues Rs m20,9844,203 499.3%   
Gross profit Rs m2,818812 347.2%  
Depreciation Rs m642417 154.1%   
Interest Rs m1,593380 419.5%   
Profit before tax Rs m96935 2,759.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-13818 -764.5%   
Profit after tax Rs m1,10717 6,511.1%  
Gross profit margin %13.719.4 70.5%  
Effective tax rate %-14.351.6 -27.7%   
Net profit margin %5.40.4 1,322.2%  
BALANCE SHEET DATA
Current assets Rs m18,8772,771 681.3%   
Current liabilities Rs m11,8961,931 616.0%   
Net working cap to sales %33.920.1 168.9%  
Current ratio x1.61.4 110.6%  
Inventory Days Days36125 28.7%  
Debtors Days Days19854 368.1%  
Net fixed assets Rs m9,8615,328 185.1%   
Share capital Rs m341114 297.8%   
"Free" reserves Rs m12,3314,177 295.2%   
Net worth Rs m16,1394,376 368.8%   
Long term debt Rs m4,7061,911 246.3%   
Total assets Rs m33,1468,428 393.3%  
Interest coverage x1.61.1 147.2%   
Debt to equity ratio x0.30.4 66.8%  
Sales to assets ratio x0.60.5 125.2%   
Return on assets %8.14.7 173.0%  
Return on equity %6.90.4 1,765.6%  
Return on capital %12.36.6 186.2%  
Exports to sales %21.40-   
Imports to sales %15.220.5 74.2%   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136858 365.4%   
Fx inflow Rs m4,4020-   
Fx outflow Rs m3,184858 371.0%   
Net fx Rs m1,219-858 -142.0%   
CASH FLOW
From Operations Rs m2,437469 519.9%  
From Investments Rs m-6,26529 -21,454.5%  
From Financial Activity Rs m2,490-464 -537.2%  
Net Cashflow Rs m-1,33735 -3,875.8%  

Share Holding

Indian Promoters % 82.7 32.9 251.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 0.2 2,388.9%  
FIIs % 5.5 0.6 948.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 66.4 11.3%  
Shareholders   10,665 20,121 53.0%  
Pledged promoter(s) holding % 85.7 36.4 235.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   WYETH LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - LUPIN LTD COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS